Javier Cortes
MD, PhD
Head, Breast Cancer Program
👥Biography 个人简介
Javier Cortes is an internationally renowned breast cancer investigator who led the DESTINY-Breast04 trial establishing trastuzumab deruxtecan as the first therapy specifically for HER2-low metastatic breast cancer. This paradigm-shifting trial expanded the population benefiting from HER2-directed therapy by approximately 50%. He is a prolific clinical trialist transforming breast cancer treatment.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Javier Cortes 的研究动态
Follow Javier Cortes's research updates
留下邮箱，当我们发布与 Javier Cortes（International Breast Cancer Center (IBCC)）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment